Evidence for the involvement of carboxyl groups in passive calcium uptake by liver plasma membrane vesicles and in agonist-induced calcium uptake by hepatocytes  by Karjalainen, Ari & Bygrave, Fyfe L.
Volume 255, number 2,441~444 FEB 07651 September 1989 
Evidence for the involvement of carboxyl groups in passive calcium 
uptake by liver plasma membrane vesicles and in agonist-induced 
calcium uptake by hepatocytes 
Ari Karjalainen and Fyfe L. Bygrave 
Department of Biochemistry, Faculty of Science, Australian National University, Canberra, ACT 2601, Australia 
Received 10 July 1989 
The hydrophobic reagents DCCD and EEDQ, each of which reacts with protein carboxyl groups, were found to inhibit 
both passive Ca*+ uptake by plasma membrane vesicles isolated from rat liver and agonist-induced Caz+ uptake by hepa- 
tocytes. The data raise the possibility that the CP+ inflow pathway(s) in liver has a specific requirement for a reactive 
carboxyl group or groups. 
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1. INTRODUCTION 
Stimulation of cellular Ca” uptake in liver is a 
major response consequent to the action of LY- 
adrenergic agonists (for a recent review see [l]). 
The chemical nature of the stimuli that induce such 
uptake is still largely unknown, although there are 
suggestions that inositol 1,3,4,5tetraphosphate 
[2,3] and/or GTP [4] might be involved. Similarly, 
the route(s) by which the ion traverses the plasma 
membrane in gaining access to the cell cytoplasm is 
largely unknown. 
In efforts to characterise, in molecular terms, the 
CaZf uptake route in liver, we described initially a 
passive Ca2+ uptake process in plasma membrane 
vesicles obtained from rat liver that occurs in- 
dependently of ATP hydrolysis and which has 
properties typical of a protein-catalysed process 
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[5]. Since we have been unable so far to hormonally 
stimulate this uptake by isolated vesicles [5] it has 
yet to be determined if this pathway is the same as 
that involved in agonist-induced Ca2+ inflow as 
observed in hepatocytes and in perfused rat liver. 
This paper describes the next stage in this charac- 
terisation, namely that of ascertaining whether 
specific group reative reagents, capable of interac- 
ting with carboxyl groups on proteins, inhibit Ca2+ 
uptake in these vesicles and in hepatocytes. 
2. EXPERIMENTAL 
Plasma membrane vesicles were isolated from male Wistar 
rats of approx. 300 g body weight exactly as described previous- 
ly [6]. Hepatocytes were prepared by a modification of the 
methods described by Berry and Friend [7] and Barritt et al. [8] 
as indicated in Altin and Bygrave [9] except hat the final wash 
was carried out with complete Eagle’s minimal essential medium 
containing 6OO/rM Ca*’ and 10 mM Hepes buffer @H 7.4) 
without phenol red. The cells were resuspended in this medium 
(10 mg cells wet weight/ml), dispensed in 1 ml portions and in- 
cubated for 20 min at 37°C before the addition of any agents. 
Cell viability, as judged by the exclusion of Trypan blue, always 
exceeded 90%. 
Passive influx of 45Ca2+ by freshly isolated membrane vesicles 
was determined by membrane filtration as described by Bygrave 
et al. [5]. 
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Influx of 4sCa2+ into hepatocytes was carried out as described 
by Biden et al. [3]. Other details are included in the legends to 
the figures. All experiments were carried out with constant shak- 
ing and gassing with Oz/CO2 (19: 1). 
Data shown are from one of at least 3 experiments that gave 
similar results. 
3. RESULTS AND DISCUSSION 
Information about the molecular nature of the 
protein(s) involved in Ca2+ uptake/influx by cells is 
confined largely to those proteins that have been 
isolated from ‘excitable’ cells. The molecular char- 
acterisation of these calcium channels has been aid- 
ed considerably by the discovery and application of 
calcium antagonists that block Ca2+ entry into cells 
of several tissues like the myocardium, the brain, 
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the smooth muscle cells of the gut and vasculature 
and skeletal muscle. One such antagonist, 1,4-di- 
hydropyridine (nifedipine), has proved particularly 
useful in that as a radioligand, it has provided a 
means to isolate and characterise the Ca2’ channel 
in several tissues (for reviews see [lo, 111). The ap- 
parent lack of inhibition by these calcium channel 
blockers of Ca2+ inflow in liver unfortunately 
prevents this approach to be adopted in that tissue. 
Some time ago Williams [12] pointed out that the 
principal groups to which Ca2+ binds are oxyan- 
ions such as carboxylates and phosphates and that 
in model complexes the binding strength of Ca2+ 
can be shown to be related to the number of car- 
boxylates. With this knowledge in mind, and in an 
extension of our interest in the mechanisms of Ca2+ 
inflow into liver cells (for a review see e.g. Altin 
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Fig. 1. Inhibition by EEDQ of passive Ca2’ uptake by plasma membrane vesicles and of agonist-induced Ca” uptake by hepatocytes. 
Passive Ca2+ uptake (A) was measured in an incubation medium consisting of 120 mM NaCl, 12 mM Hepes buffer and 5 mM KC1 in 
500 ~1 final volume at 37”C, pH 7.4. EEDQ, dissolved in DMSO, was added as indicated and the control contained an equal concentra- 
tion of DMSO alone; the final DMSO concentration was 1%. Membrane vesicles (250 pg protein per reaction medium) were prein- 
cubated for 15 min with the added agents prior to the addition of radiolabelled Ca” containing 100 CM ‘%a2+. Samples were then 
taken at the times indicated, filtered through Sartorious membrane filters (0.2 FM pore size), immediately washed with 2.0 ml of incuba- 
tion medium containing 1 mM EGTA to remove non-sequestered 45CaZ+, the filters dried and counted for radioactivity as described 
in [5]. Agonist-induced Ca” uptake by hepatocytes (B) was measured in an incubation medium consisting of Krebs-Henseleit bicar- 
bonate buffer @H 7.4) containing physiological amino acids, 5 mM glucose and 0.5% defatted bovine serum albumin in a final volume 
of 1 ml; all experiments were carried out at 37°C with constant shaking and gassing with Oz/COz (19: 1). Following a 20-min preincuba- 
tion period, EEDQ with or without aniline or DMSO alone in the case of the control, were added. One min later 100 nM glucagon or 
200 1M CAMP was added and a further 1 min later 100 nM vasopressin. 30 s after the addition of the final hormone, tracer 4’Ca2+ 
(0.63 &i) was added, lOO-~1 samples then taken at the times indicated and washed on Millipore membrane filters (5 ,um pore size) with 
approx. 4 ml of a cold solution containing 135 mM NaCl, 12 mM Hepes, 2 mM EGTA (PH 7.4). The filters were then dissolved and 
counted as described in [3]. Maximal Ca*+ uptake (i.e. 100%) for (A) was 1.5 nmol/mg protein, and for (B) 2 nmol/mg cells wet wt. 
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and Bygrave [l]), we examined the effect of several 
N,N’-disubstituted carbodiimides (see e.g. [ 131) 
and of an N-carbethoxydihydroquinoline [ 141, 
compounds that have been used widely as protein 
carboxyl groups modifying reagents (see e.g. 1151). 
This examination has been carried out on Ca2+ up- 
take by vesicles derived from the plasma membrane 
of rat liver [5] and by hepatocytes in the presence of 
Ca’+-mobilising agonists. 
We showed recently that plasma membrane 
vesicles of rightside-out orientation isolated from 
rat liver are able to take up Ca2+ independently of 
a requirement for ATP and have argued that such 
uptake could reflect one of the pathways for Ca2+ 
inflow into liver cells [5]. Data in fig.lA show that 
such passive Ca2+ uptake is inhibited by EEDQ; 
approx. 50% inhibition of the initial rate of uptake 
is obtained with 1 mM EEDQ. Data in fig. 1B show 
that Ca2+ uptake into hepatocytes stimulated by 
the synergistic action of glucagon and vasopressin 
(reviewed in [1]) is inhibited similarly by EEDQ; 
750 ,uM EEDQ reduces the initial rate of uptake to 
a value comparable to that observed in the absence 
of the Ca’+-mobilising agonists. 
Having found that EEDQ has such inhibitory ef- 
fects, we then tested the effects of three different 
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carbodiimides. Data in fig.2A show that the hydro- 
phobic DCCD also inhibits passive Ca2+ uptake by 
the plasma membrane vesicles but that by contrast 
with DCCD and EEDQ (fig.lA), both the hydro- 
philic EDAC and the hydrophilic CMDC even at 
concentrations of 5 mM, are not so effective as in- 
hibitors. The data in fig.2B show that Ca2+ uptake 
into hepatocytes also supported by the synergistic 
action of glucagon and vasopressin, is very sen- 
sitive to the action of DCCD; 1OOpM DCCD for 
example almost completely inhibits such Ca2+ up- 
take. In these latter experiments the effects of 
EDAC and CMCD were not assessed. 
Care was taken to assess whether in the case of 
hepatocytes, the carboxyl group reactants were ac- 
ting on Ca2+ inflow and not on the ability of the 
hormones to stimulate Ca2+ uptake through for ex- 
ample their second messenger action. To examine 
this, we tested first whether DCCD and EEDQ 
would inhibit the ability of glucagon and vaso- 
pressin to stimulate glucose output. In experiments 
not shown here, we observed that these compounds 
had no effect on agonist-stimulated glucose output 
in otherwise identical experimental conditions. If 
anything, glucose output was stimulated by the 
presence of DCCD. Second, we were able to show 
Fig.2. Inhibition by DCCD of passive Ca*+ uptake by plasma membrane vesicles and of agonist-induced Ca*+ uptake by hepatocytes. 
Each set of experiments was carried out exactly as described in fig.1 except that DCCD or EDAC or CMCD was present at the concen- 
trations indicated. The values obtained for the controls in each case were similar to those indicated in fig. 1. 
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that when glucagon was replaced by cyclic AMP as 
inducer of the synergistic action on Ca” inflow 
(see [I]), or when vasopressin was replaced by 
either ATP or phenylephrine as Ca’+-mobilising 
agonist (see [16]), DCCD and EEDQ were still ef- 
fective inhibitors of Ca2+ inflow by hepatocytes. 
Results of these experiments thus led us to conclude 
that DCCD and EEDQ were having direct effects 
on the Ca2’ inflow protein/channel and not on 
either the receptors for the agonists located on the 
outer surface of the plasma membrane, or on any 
relevant site of action of any second messenger 
generated therefrom. 
4. CONCLUDING COMMENTS 
These studies extend our investigation into the 
molecular basis of Ca2+ inflow across the plasma 
membrane in liver cells and vesicles by providing 
evidence that the inflow pathway(s) appears to 
have a specific requirement for a reactive carboxyl 
group or groups. The finding that the hydrophobic 
carboxyl group reactants are more potent than the 
water-soluble carboxyl group reactants in their in- 
hibitory action on Ca2+ inflow, suggests that this 
could be an important and useful tool with which 
to study further the molecular nature of the Ca2+ 
inflow protein(s) in liver cells particularly in aiding 
the discrimination of ‘relevant’ from ‘non- 
relevant’ carboxyl groups on the external surface 
of the liver plasma membrane. 
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